These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9848155)

  • 1. [Forty years of studying angiotensin-converting enzyme: problems and accomplishments].
    Vernigora AN; Gengin MT
    Ukr Biokhim Zh (1978); 1998; 70(2):3-14. PubMed ID: 9848155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiotensin-converting enzyme and its physiological role].
    Eliseeva IuE
    Vopr Med Khim; 2001; 47(1):43-54. PubMed ID: 11385998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structural and functional characteristics of angiotensin converting enzyme].
    Eliseeva IuE
    Bioorg Khim; 1998 Apr; 24(4):262-70. PubMed ID: 9612568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.
    Erdös EG
    Hypertension; 1990 Oct; 16(4):363-70. PubMed ID: 2170273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and physiological significance of angiotensin converting enzyme domains].
    Eliseeva IuE; Kugaevskaia EV
    Biomed Khim; 2009; 55(4):397-414. PubMed ID: 20000120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
    Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J
    J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme.
    Tzakos AG; Naqvi N; Comporozos K; Pierattelli R; Theodorou V; Husain A; Gerothanassis IP
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5084-7. PubMed ID: 16889963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
    Husain A; Li M; Graham RM
    Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
    Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
    Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C domain-selective inhibition of angiotensin-converting enzyme.
    Ehlers MR; Abrie JA; Sturrock ED
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):189-92. PubMed ID: 23686914
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene.
    Soubrier F; Hubert C; Testut P; Nadaud S; Alhenc-Gelas F; Corvol P
    J Hypertens; 1993 May; 11(5):471-6. PubMed ID: 8390518
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptidyl dipeptidase A: angiotensin I-converting enzyme.
    Corvol P; Williams TA; Soubrier F
    Methods Enzymol; 1995; 248():283-305. PubMed ID: 7674927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physico-chemical characteristics of angiotensin-converting enzyme from the bovine lung].
    Kost OA; Lamzina NA; Sharafutdinov TZ; Tsuprun VL; Kazanskaia NF
    Biokhimiia; 1990 Jun; 55(6):974-81. PubMed ID: 2169907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The active site specificity of angiotensin II converting enzyme 2 investigated through single and multiple residue changes and beta-amino acid substrate analogs.
    Clayton D; Hanchapola I; Perlmutter P; Smith AI; Aguilar MI
    Adv Exp Med Biol; 2009; 611():559-60. PubMed ID: 19400312
    [No Abstract]   [Full Text] [Related]  

  • 15. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin I-converting enzyme.
    Erdös EG; Skidgel RA
    Lab Invest; 1987 Apr; 56(4):345-8. PubMed ID: 3031365
    [No Abstract]   [Full Text] [Related]  

  • 17. Physiological and pharmacological aspects of angiotensin converting enzyme.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Hortling L
    Scand J Urol Nephrol Suppl; 1984; 79():39-43. PubMed ID: 6089317
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of human angiotensin converting enzyme by copper peptide complexes containing ATCUN motifs.
    Gokhale NH; Cowan JA
    Chem Commun (Camb); 2005 Dec; (47):5916-8. PubMed ID: 16317474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of catalytic activity and supramolecular structure of angiotensin-converting enzyme in reversed micelles of aerosol OT in octane].
    Kost OA; Ort TA; Nikol'skaia II; Nametkin SN; Lebashov AV
    Biokhimiia; 1994 Nov; 59(11):1746-55. PubMed ID: 7533006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of angiotensin-converting enzyme (kininase II) in neuropeptide metabolism.
    Yokosawa H; Ohgaki Y; Satoh M; Fujii Y; Endo S; Ishii S
    Adv Exp Med Biol; 1989; 247B():371-6. PubMed ID: 2481947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.